Immediate Impact
3 by Nobel laureates 11 from Science/Nature 62 standout
Citing Papers
Modulation of the tumor microenvironment and mechanism of immunotherapy-based drug resistance in breast cancer
2024 Standout
Natural killer cell therapies
2024 StandoutNature
Works of Michael Chisamore being referenced
Phase 1b/2, open label, multicenter, study of the combination of SD-101 and pembrolizumab in patients with advanced melanoma who are naïve to anti-PD-1 therapy.
2019
Abstract LB-129: Imprime PGG, a soluble yeast β-glucan PAMP, in combination with Pembrolizumab induces infiltration and activation of both innate and adaptive immune cells within tumor sites in melanoma and triple-negative breast cancer (TNBC) patients
2018
Author Peers
| Author | Last Decade | Papers | Cites | ||||
|---|---|---|---|---|---|---|---|
| Michael Chisamore | 548 | 204 | 245 | 365 | 107 | 944 | |
| Amy Weise | 508 | 249 | 181 | 423 | 68 | 902 | |
| Gianmaria Miolo | 381 | 161 | 122 | 401 | 85 | 935 | |
| Hui Zeng | 349 | 152 | 230 | 388 | 55 | 985 | |
| Mutsuko Yamamoto‐Ibusuki | 440 | 247 | 180 | 544 | 45 | 1.1k | |
| Geraldine O’Sullivan Coyne | 624 | 298 | 185 | 350 | 78 | 1.1k | |
| Sara Tomei | 529 | 129 | 403 | 512 | 56 | 1.1k | |
| Piotr Donizy | 443 | 97 | 180 | 419 | 87 | 1.0k | |
| Meili Sun | 544 | 269 | 245 | 309 | 110 | 1.1k | |
| Shunsuke Yanoma | 487 | 172 | 214 | 410 | 53 | 1.2k | |
| Roger Mouawad | 300 | 150 | 205 | 511 | 57 | 946 |
All Works
Login with ORCID to disown or claim papers
Loading papers...